drugset / Trial / NCT00385268
Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
Phase 2
Completed
60 enrolled
University of Pennsylvania
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Trial to determine the safety, efficacy and tolerability of acamprosate for the treatment of cocaine dependence.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-05
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acamprosate | Small molecule | 666 mg | — |